Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in Angiosarcoma
NCT01462630Phase 2Completed
- Sponsor
- Fox Chase Cancer Center
- Start
- Nov 2011
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in angiosarcoma, sponsored by Fox Chase Cancer Center. Started Nov 2011; status: completed.
02
Drugs
pazopanib
03
Conditions
angiosarcoma
Beyond the preview
Go deeper on NCT01462630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01462630.